Role of cyclodextrins in therapeutic strategies of COVID-19
https://doi.org/10.56626/egis.v1i1.8938
Authors
View
Keywords
License
Copyright (c) 2022 Health Innovation Review
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Az Egészségügyi Innovációs Szemle folyóiratban megjelenő cikkek szabadon megoszthatók, másolhatók az anyagok bármilyen megjelenési formájában a "CC Attribution-NonCommercial-NoDerivatives 4.0" licenszben szereplő szabályok betartásával.
A cikkek változtatás nélkül terjeszthetők, és kereskedelmi felhasználásuk tilos.
How To Cite
Abstract
Since the emergence of the SARS-CoV-2 virus in late 2019, several therapeutic possibilities have appeared to treat patients who are often in severe condition due to the pathogen. As more information becomes available about the virus, the therapeutic strategies can be more specific. Cyclodextrins are well known molecules in the pharmaceutical industry. Due to their special structure they can be widely used in drug development. One of our main research topic is the application of cyclodextrins, so considering the current pandemic situation, it was relevant for us to summarize the role of cyclodextrin molecules in the therapy of COVID-19 disease. In the course of our literary research, we have found many interesting theories and promising developments.